Adriana Sánchez Danés, PhD, Cancer and Stem Cell Biology Lab
Seminar room
In this seminar, I will present recent advances developed in our laboratory in CAR-based adoptive T-cell immunotherapy, with a particular focuss on leukemia. The talk will highlight γδ T cells as allogeneic effector platforms and explore emerging dual-targeting and armored CAR strategies.